A simple test could transform the lives of thousands of women with breast cancer by leading to more effective and individualised treatments, experts have said.
Genome sequencing could help more than 15,000 women a year benefit from “precisely” tailored care by analysing their DNA to understand their tumour and their likely response to certain treatments, scientists added.
